MC

544.1

-1.98%↓

SANES

5.555

-9.84%↓

BNP

68.74

-8.1%↓

CS.FR

37.94

-4.53%↓

ALV

339.2

-4.32%↓

MC

544.1

-1.98%↓

SANES

5.555

-9.84%↓

BNP

68.74

-8.1%↓

CS.FR

37.94

-4.53%↓

ALV

339.2

-4.32%↓

MC

544.1

-1.98%↓

SANES

5.555

-9.84%↓

BNP

68.74

-8.1%↓

CS.FR

37.94

-4.53%↓

ALV

339.2

-4.32%↓

MC

544.1

-1.98%↓

SANES

5.555

-9.84%↓

BNP

68.74

-8.1%↓

CS.FR

37.94

-4.53%↓

ALV

339.2

-4.32%↓

MC

544.1

-1.98%↓

SANES

5.555

-9.84%↓

BNP

68.74

-8.1%↓

CS.FR

37.94

-4.53%↓

ALV

339.2

-4.32%↓

Search

Eurazeo SE

Open

BrancheFinanzen

62.1 -5.98

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

62.2

Max

66.15

Schlüsselkennzahlen

By Trading Economics

Einkommen

-105M

Verkäufe

104M

Dividendenrendite

3.89

Gewinnspanne

-100.723

EBITDA

-51M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+48.81% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

3.89%

3.90%

Nächstes Ergebnis

10. Apr. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

5.1B

Vorheriger Eröffnungskurs

68.08

Vorheriger Schlusskurs

62.1

Nachrichtenstimmung

By Acuity

41%

59%

170 / 542 Ranking in Finance

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

Eurazeo SE Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Sept. 2024, 06:28 UTC

Akquisitionen, Fusionen, Übernahmen

EQT Leads $102.5 Million Series A Funding Round in Belgian Radioisotope Producer PanTera

Peer-Vergleich

Kursveränderung

Eurazeo SE Prognose

Kursziel

By TipRanks

48.81% Vorteil

12-Monats-Prognose

Durchschnitt 100 EUR  48.81%

Hoch 100 EUR

Tief 100 EUR

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Eurazeo SE – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

1

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

N/A / 71.95Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

170 / 542 Ranking in Finanzen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Eurazeo SE

Eurazeo SE is a private equity and venture capital firm specializing in growth capital, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in mid-market and listed public companies. The company invest in equity in the small-mid and Mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in United States, France, Italy, North America and other European countries. It seeks to invest between "50 million ($54.35 million) to "250 million ($271.77 million) in small mid buyout business. It seeks to invest between "25 million ($27.18 million) to "100 million ($108.71 million) in growth business. It seeks to invest between "10 million ($10.82 million) and "40 million ($43.82 million) in the fields of healthcare research. It seeks to invests between equity investment between "1 million ($1.17 million) and "559.01 mil